Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2026-02-27 @ 10:33 AM
Study NCT ID:
NCT02614794
Status:
COMPLETED
Last Update Posted:
2023-08-14
First Post:
2015-11-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer
Sponsor:
Seagen Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | HER2 Positive Breast Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Tucatinib | View |
| None | Capecitabine | View |
| None | Trastuzumab | View |
| None | Xeloda | View |
| None | Herceptin | View |
| None | Breast Cancer | View |
| None | ARRY-380 | View |
| None | ONT-380 | View |
| None | HER2 Positive Breast Carcinoma | View |
| None | HER2 Positive Locally Advanced Breast Cancer | View |
| None | HER-2 Positive Breast Cancer | View |
| None | HER-2 Positive Breast Carcinoma | View |
| None | HER-2 Positive Locally Advanced Breast Cancer | View |
| None | Recurrent Breast Carcinoma | View |
| None | Stage IV Breast Cancer | View |
| None | Metastatic Breast Cancer | View |
| None | Breast Carcinoma | View |
| None | Metastatic Malignant Neoplasm in the Brain | View |
| None | Brain Metastases in Breast Cancer | View |
| None | Asymptomatic Brain Metastases in Breast Cancer | View |
| None | Low Symptomatic Brain Metastases in Breast Cancer | View |
| None | Seattle Genetics | View |